Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 5
2008 4
2009 2
2010 3
2011 5
2012 4
2013 2
2014 5
2015 1
2016 2
2017 6
2018 5
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Targeting CDC7 sensitizes resistance melanoma cells to BRAFV600E-specific inhibitor by blocking the CDC7/MCM2-7 pathway.
Gad SA, Ali HEA, Gaballa R, Abdelsalam RM, Zerfaoui M, Ali HI, Salama SH, Kenawy SA, Kandil E, Abd Elmageed ZY. Gad SA, et al. Among authors: ali hi. Sci Rep. 2019 Oct 2;9(1):14197. doi: 10.1038/s41598-019-50732-w. Sci Rep. 2019. PMID: 31578454 Free PMC article.
LY2087101 and dFBr share transmembrane binding sites in the (α4)3(β2)2 Nicotinic Acetylcholine Receptor.
Deba F, Ali HI, Tairu A, Ramos K, Ali J, Hamouda AK. Deba F, et al. Among authors: ali hi. Sci Rep. 2018 Jan 19;8(1):1249. doi: 10.1038/s41598-018-19790-4. Sci Rep. 2018. PMID: 29352227 Free PMC article.
Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients.
Ali HEA, Lung PY, Sholl AB, Gad SA, Bustamante JJ, Ali HI, Rhim JS, Deep G, Zhang J, Abd Elmageed ZY. Ali HEA, et al. Among authors: ali hi. Sci Rep. 2018 Nov 5;8(1):16335. doi: 10.1038/s41598-018-34637-8. Sci Rep. 2018. PMID: 30397274 Free PMC article.
Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition.
Malki WH, Gouda AM, Ali HEA, Al-Rousan R, Samaha D, Abdalla AN, Bustamante J, Abd Elmageed ZY, Ali HI. Malki WH, et al. Among authors: ali hi. Eur J Med Chem. 2018 May 25;152:31-52. doi: 10.1016/j.ejmech.2018.04.029. Epub 2018 Apr 17. Eur J Med Chem. 2018. PMID: 29684708
Synthesis and molecular docking study of new benzofuran and furo[3,2-g]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitors.
Amin KM, Syam YM, Anwar MM, Ali HI, Abdel-Ghani TM, Serry AM. Amin KM, et al. Among authors: ali hi. Bioorg Chem. 2018 Feb;76:487-500. doi: 10.1016/j.bioorg.2017.12.029. Epub 2018 Jan 2. Bioorg Chem. 2018. PMID: 29310080
Exosomes are the Driving Force in Preparing the Soil for the Metastatic Seeds: Lessons from the Prostate Cancer.
Saber SH, Ali HEA, Gaballa R, Gaballah M, Ali HI, Zerfaoui M, Abd Elmageed ZY. Saber SH, et al. Among authors: ali hi. Cells. 2020 Feb 28;9(3):564. doi: 10.3390/cells9030564. Cells. 2020. PMID: 32121073 Free PMC article. Review.
Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds.
Abdelhafez OM, Ahmed EY, Abdel Latif NA, Arafa RK, Abd Elmageed ZY, Ali HI. Abdelhafez OM, et al. Among authors: ali hi. Bioorg Med Chem. 2019 Apr 1;27(7):1308-1319. doi: 10.1016/j.bmc.2019.02.027. Epub 2019 Feb 15. Bioorg Med Chem. 2019. PMID: 30792101
Pyrrolizines: Design, synthesis, anticancer evaluation and investigation of the potential mechanism of action.
Gouda AM, Abdelazeem AH, Omar HA, Abdalla AN, Abourehab MAS, Ali HI. Gouda AM, et al. Among authors: ali hi. Bioorg Med Chem. 2017 Oct 15;25(20):5637-5651. doi: 10.1016/j.bmc.2017.08.039. Epub 2017 Aug 24. Bioorg Med Chem. 2017. PMID: 28916158
Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors.
Galal SA, Khairat SHM, Ali HI, Shouman SA, Attia YM, Ali MM, Mahmoud AE, Abdel-Halim AH, Fyiad AA, Tabll A, El-Shenawy R, El Abd YS, Ramdan R, El Diwani HI. Galal SA, et al. Among authors: ali hi. Eur J Med Chem. 2018 Jan 20;144:859-873. doi: 10.1016/j.ejmech.2017.12.023. Epub 2017 Dec 8. Eur J Med Chem. 2018. PMID: 29316526
The plasticizer BBP selectively inhibits epigenetic regulator sirtuins.
Zhang J, Ali HI, Bedi YS, Choudhury M. Zhang J, et al. Among authors: ali hi. Toxicology. 2015 Dec 2;338:130-41. doi: 10.1016/j.tox.2015.10.004. Epub 2015 Oct 28. Toxicology. 2015. PMID: 26520405
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback